Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hal Rice

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Stroke|October 17, 2025
Acute Carotid Stenting for Tandem Lesions in Patients Randomized to Endovascular Treatment With or Without Thrombolysis: Results From the IRIS Individual Participant Data Meta-AnalysisFabiano Cavalcante, Kilian M Treurniet, Johannes Kaesmacher, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
Stroke|November 23, 2022
Ultra-Long Transfers for Endovascular Thrombectomy-Mission Impossible?: The Australia-New Zealand ExperienceCarlos Garcia-Esperon, Teddy Y Wu, Vinicius Carraro do Nascimento, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Stroke|October 17, 2025
Acute Carotid Stenting for Tandem Lesions in Patients Randomized to Endovascular Treatment With or Without Thrombolysis: Results From the IRIS Individual Participant Data Meta-AnalysisFabiano Cavalcante, Kilian M Treurniet, Johannes Kaesmacher, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
Stroke|November 23, 2022
Ultra-Long Transfers for Endovascular Thrombectomy-Mission Impossible?: The Australia-New Zealand ExperienceCarlos Garcia-Esperon, Teddy Y Wu, Vinicius Carraro do Nascimento, et al.
Pageof 4